Records containing: Multiple Sclerosis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2012-07-27A Comparative Single Center, Randomized Neuropathic Pain Assessment Study Involving Patients With Clinically Definite Multiple Sclerosis (MS) Receiving Treatment With Either Pregabalin or Paroxetine
-
CLINICAL_TRIALS study record update · 2012-07-27A Comparative, Single Center, Randomized, Double-blinded, Parallel, Placebo-controlled Study to Evaluate the Efficacy of Nabilone (Cesamet) as Adjunctive Therapy to Gabapentin (Neurontin) in the Management of Neuropathic Pain (NPP) Symptoms in Subjects With Multiple Sclerosis (MS)
-
CLINICAL_TRIALS study record update · 2012-07-12An Extension of the 24-month, Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing Efficacy and Safety of Fingolimod (FTY720) 1.25 mg and 0.5 mg Administered Orally Once Daily Versus Placebo in Patients With Relapsing-remitting Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2012-07-04A Double Blind, Randomised, Placebo Controlled, Parallel Group Study of Sativex When Added to the Existing Treatment Regimen, in the Relief of Central Neuropathic Pain in Subjects With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2012-06-2624-month Double-blind, Randomized, Multicenter, Placebo-controlled, Parallel-group Study Comparing the Efficacy and Safety of 0.5 mg and 1.25 mg Fingolimod (FTY720) Administered Orally Once Daily Versus Placebo in Patients With Relapsing-remitting Multiple Sclerosis With Optional Extension Phase
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2012-06-18The Role of Leptin Levels in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2012-06-15A Randomized Exercise Trial for Wheelchair Users
-
CLINICAL_TRIALS study record update · 2012-06-14Immunoregulation by Controlled Parasite Exposure in Multiple Sclerosis.
-
CLINICAL_TRIALS study record update · 2012-06-13A Multinational, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group Study to Evaluate the Effect of Early Glatiramer Acetate Treatment in Delaying the Conversion to Clinically Definite Multiple Sclerosis (CDMS) of Subjects Presenting With Clinically Isolated Syndrome (CIS)
-
CLINICAL_TRIALS study record update · 2012-06-08Pilot Clinical Trial With Memantine for Cognitive Deficits in Patients With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2012-05-30Betaferon Treatment and Exercise Data Gathering IN Early MS
-
CLINICAL_TRIALS study record update · 2012-05-21Prospective, Randomized, Double-blind, Placebo-controlled Study on Parallel Groups Evaluating the Efficacy and Safety of Cranberry (Vaccinium Macrocarpon) in Prevention of Urinary Tract Infections in Multiple Sclerosis Patients.
-
CLINICAL_TRIALS study record update · 2012-05-09Cognitive Testing for the Pain Quality Assessment Scale (PQAS)
-
CLINICAL_TRIALS study record update · 2012-05-03Psychometric Validation of Cognitive Endpoints
-
CLINICAL_TRIALS study record update · 2012-04-09Randomised, Double-blind, Placebo-controlled, Parallel-group, Dose-ranging Study to Investigate the MRI Efficacy and the Safety of Six Months Administration of SB-683699 in Subjects With Relapsing-Remitting Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2012-03-23Comparison of the Cognitive Effects of Three Immunomodulatory Drugs in Relapsing-Remitting Multiple Sclerosis: A Longitudinal Study
-
CLINICAL_TRIALS study record update · 2012-03-07Herbal Therapy for Subcutaneous Injection Site Reactions in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2012-03-07Utility of Chronic Cerebrospinal Venous Insufficiency Percutaneous Angioplasty for Multiple Sclerosis: The Albany Vascular Group Study (Liberation Study)
-
CLINICAL_TRIALS study record update · 2012-03-05Extension Study of the BENEFIT (304747) and BENEFIT Follow-up (305207) Studies to Further Evaluate the Progress of Patients With First Demyelinating Event Suggestive of Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2012-03-01Pharmacokinetic, Immunological and Biochemical Sample Collection and Analysis of a Tysabri Patient Cohort
-
CLINICAL_TRIALS study record update · 2012-02-29Phase 3 Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2012-02-27Phase 3 Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis Who Participated in the MS-F204 Trial
-
CLINICAL_TRIALS study record update · 2012-02-27Phase 3 Open-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Subjects With Multiple Sclerosis Who Participated in the MS-F203 Trial
-
CLINICAL_TRIALS study record update · 2012-02-24A 16-week, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy of Rivastigmine Patch (10 cm²) on Cognitive Deficits in Patients With Multiple Sclerosis, Followed by a 1-year Open-label Treatment Phase
-
CLINICAL_TRIALS study record update · 2012-02-08Evaluation of [18F] FEPPA and PET as a Marker of Inflammation in Subjects With Neurological Conditions